SCHEMBL3832035

SCHEMBL3832035

CCCCC(c1nc2cc(-c3ncc[nH]3)ccc2[nH]1)c1nc2cc(-c3ncc[nH]3)ccc2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP19A1 P11511 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
VCP P55072 2/20 0.39
ALDH1A1 P00352 3/20 0.38
NISCH Q9Y2I1 2/20 0.38
TLR9 Q9NR96 1/20 0.37
TLR8 Q9NR97 1/20 0.37
TLR7 Q9NYK1 1/20 0.37
MTOR P42345 1/20 0.36
ADK P55263 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
KDM4E B2RXH2 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AAK1 Q2M2I8 4/20 0.34
ATP4A P20648 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4438276 0.93 CYP1A2 (0.42) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL3835607 0.88 NISCH (0.41) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL5311167 0.85 CYP1A2 (0.41) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL5313354 0.84 NISCH (0.36) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL3835598 0.83 TLR9 (0.39) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL4392245 0.82 ALDH1A1 (0.40) ALDH1A1TLR8TLR7KDM4ESMN1; SMN2
SCHEMBL3837411 0.81 NISCH (0.44) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL3836481 0.81 NISCH (0.37) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL3837147 0.80 NISCH (0.37) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9
SCHEMBL5311172 0.79 CYP1A2 (0.48) CYP1A2CYP3A4CYP2D6CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004006849-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS COMBINATORX, INCORPORATED (US) 2004-01-22 WO claimed
EP-2121700-A1 SUBSTITUTED TETRAHYDROQUINOLINES Merck Patent GmbH (DE) 2009-11-25 EP disclosed
EP-2121706-A1 TETRAHYDROQUINOLINE DERIVATIVES AND USE OF SAME FOR TREATING CANCER Merck Patent GmbH (DE) 2009-11-25 EP disclosed
EP-2121684-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINES Merck Patent GmbH (DE) 2009-11-25 EP disclosed
EP-2104664-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN Merck Patent GmbH (DE) 2009-09-30 EP disclosed
WO-2008113452-A1 SUBSTITUTED TETRAHYDROPYRROLOQUINOLINES MERCK PATENT GMBH (DE) 2008-09-25 WO disclosed
WO-2008113451-A1 SUBSTITUTED TETRAHYDROQUINOLINES MERCK PATENT GMBH (DE) 2008-09-25 WO disclosed
WO-2008113456-A1 TETRAHYDROQUINOLINE DERIVATIVES AND USE OF SAME FOR TREATING CANCER MERCK PATENT GMBH (DE) 2008-09-25 WO disclosed
WO-2008080455-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2008-07-10 WO disclosed
EP-1891011-A1 TETRAHYDROQUINOLINES USED IN THE FORM OF MODULATORS OF MITOTIC MOTOR-PROTEINS EG5 Merck Patent GmbH (DE) 2008-02-27 EP disclosed
WO-2006133805-A1 TETRAHYDROQUINOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2006-12-21 WO disclosed
WO-2006125555-A2 QUINAZOLINONES MERCK PATENT GMBH (DE) 2006-11-30 WO disclosed
WO-2006097176-A1 PHTHALAZINONES MERCK PATENT GMBH (DE) 2006-09-21 WO disclosed
WO-2006002726-A1 TETRAHYDROQUINOLINES MERCK PATENT GMBH (DE) 2006-01-12 WO disclosed
WO-2005108355-A2 DIHYDROBENZOTHIOPHENES MERCK PATENT GMBH (DE) 2005-11-17 WO disclosed
WO-2005063735-A1 2-(HETERO)-ARYL-SUBSTITUTED TETRAHYDROQUINOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2005-07-14 WO disclosed
EP-1545544-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS Combinatorx, Incorporated (US) 2005-06-29 EP disclosed
WO-2004006842-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS COMBINATORX, INCORPORATED (US) 2004-01-22 WO disclosed
WO-2004006849-A2 COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS COMBINATORX, INCORPORATED (US) 2004-01-22 WO disclosed
WO-2004002430-A2 COMBINATIONS FOR THE TREATMENT OF FUNGAL INFECTIONS COMBINATORX INCORPORATED (US) 2004-01-08 WO disclosed